Followers | 10 |
Posts | 343 |
Boards Moderated | 0 |
Alias Born | 10/28/2011 |
Friday, March 23, 2012 1:03:13 PM
Verisante is overdue and vastly undervalued at this point. Everyone, with few exceptions who has done significant research in this segment, is well aware. LOOK AT THE MARKET SEGMENT. When compared with the competition, having a 25x larger potential market for these devices, detecting not only melanoma but also the other 96% of skin cancers, consuming a fraction of the time 1 second vs. 2 minute scan time, and costing a fraction of the per-use-price for MD end-users $50 scan vs. $10/per disposable tip; Verisante brings only one word to mind.
SUPREMECY only becomes more well established with each news release. further, with the current securities lawsuit faced by the nearest competitor in this sector, having two, not 1 but count 'em 2-securities attorneys at the helm for Verisante is no laughing matter unless, of course, you take stock in VRS-canada/VRSEF-usa/V3T-germany.
LOVING IT,
Walt
FEATURED Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM